褪黑素经三叉神经节MT2R缓解颞下颌关节骨关节炎慢性疼痛
本研究在大鼠颞下颌关节骨关节炎(TMJOA)模型中探究褪黑素(MT)缓解慢性疼痛的作用与机制。结果显示TMJOA患者和大鼠滑液中MT水平升高,三叉神经节(TG)神经元MT2R上调;外源性MT可缓解大鼠慢性疼痛,而MT2R拮抗剂4P-PDOT可逆转该镇痛效应。机制上MT通过MT2R抑制TG神经元CGRP和IB4表达。
要点
- TMJOA慢性疼痛大鼠TG神经元MT2R表达上调。
- 外源性褪黑素经MT2R缓解TMJOA大鼠慢性疼痛。
- 褪黑素抑制TG神经元CGRP和IB4表达,可被MT2R拮抗剂逆转。
核心结论
- 褪黑素通过MT2R下调TG中敏化的CGRP+和IB4+神经元,缓解大鼠TMJOA慢性疼痛。
研究设计与样本
- 大鼠TMJOA慢性疼痛模型:颞下颌关节内注射碘乙酸钠,第14天出现慢性疼痛。
- 采用酶联免疫吸附试验检测患者和大鼠滑液MT水平,荧光逆行追踪(Dil)标记支配颞下颌关节的TG神经元。
- 通过von Frey和Rat Grimace Scale评估伤害性行为,免疫荧光分析TG神经元CGRP和IB4表达,体外Fluo-3 AM钙成像检测MT引起的钙瞬变。
主要发现
- TMJOA患者和大鼠滑液中MT水平高于对照组。
- 支配大鼠颞下颌关节的TG神经元中MT2R上调,伴随TMJOA慢性疼痛。
- 外源性MT缓解TMJOA大鼠慢性疼痛,4P-PDOT阻断MT2R可逆转镇痛效果。
- MT抑制TG神经元CGRP和IB4表达,给予MT2R拮抗剂可逆转该抑制。
- MT在Dil+ TG神经元引起钙瞬变,可被4P-PDOT显著消除。
临床怎么用
- 褪黑素可作为TMJOA慢性疼痛的潜在治疗选项,机制涉及TG神经元MT2R。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Temporomandibular joint osteoarthritis (TMJOA) is one of the most common diseases causing chronic pain in the oral and maxillofacial region. So far, there are few ways to relieve the pain of TMJOA. Melatonin (MT) has a good analgesic effect in many diseases, including fibromyalgia, neuropathic pain, chronic headache, and burn pain, with very low acute toxicity and side effects. This study was to investigate the role and mechanism of MT in TMJOA chronic pain. In rats TMJOA chronic pain occurred at day 14 after an intra-temporomandibular joint injection of monosodium iodoacetate, which we previously reported. The enzyme-linked immunosorbent assay results showed that MT levels were higher in the synovial fluid from patients and rats with TMJOA as compared with those from control. Fluorescent retrograde tracing (Dil) identified that upregulation of MT type 2 receptor (MT2R) in trigeminal ganglion (TG) neurons innervating rat temporomandibular joints was accompanied by TMJOA chronic pain. Nociceptive behavior as assessed by von Frey and the Rat Grimace Scale demonstrated that exogenous administration of MT relieved chronic pain in TMJOA rats, whereas blocking MT2R with 4P-PDOT reversed the analgesic effect of MT. Immunofluorescence analysis also confirmed that MT inhibited CGRP and IB4 expression of TG neurons, and this inhibition was reversed by administering the MT2R antagonist in TMJOA rats. By using Fluo-3 AM-based calcium imaging in vitro, MT elicited calcium transients in Dil+ TG neurons, which were significantly abolished by 4P-PDOT. Collectively, this study suggested that MT relieves the TMJOA chronic pain of rats through downregulation of sensitized CGRP+ and IB4+ neurons in TG via MT2R. This will be helpful for health care professionals utilizing MT as an option against TMJOA chronic pain.
引用
- Liu W, Jiang H, Liu X, et al. Melatonin Abates TMJOA Chronic Pain by MT2R in Trigeminal Ganglion Neurons. J Dent Res. 2021. PMID: 34315312. doi:10.1177/00220345211026551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。